<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Holmberg D</submitter><funding>Vetenskapsrådet</funding><funding>Cancerfonden</funding><pagination>2901-2908</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6684532</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Individuals with Barrett's esophagus (BE) are at increased risk of high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC), but the cost-effectiveness of general surveillance of BE is low. This study aimed to identify a risk prediction model for tumor progression in individuals with BE based on age, sex, and risk factors found at upper endoscopy, enabling tailored surveillance.&lt;h4>Methods&lt;/h4>This nested case-control study originated from a cohort of 8171 adults diagnosed with BE in 2006-2013 in the Swedish Patient Registry. Cases had EAC/HGD (n = 279) as identified from the Swedish Cancer Registry, whereas controls had no EAC/HGD (n = 1089). Findings from endoscopy and histopathology reports were extracted from medical records at 71 Swedish hospitals and from the</pubmed_abstract><journal>Surgical endoscopy</journal><pubmed_title>Clinical prediction model for tumor progression in Barrett's esophagus.</pubmed_title><pmcid>PMC6684532</pmcid><funding_grant_id>CAN 2015/460</funding_grant_id><funding_grant_id>E0253601</funding_grant_id><funding_grant_id>D0547801</funding_grant_id><pubmed_authors>Lagergren J</pubmed_authors><pubmed_authors>Holmberg D</pubmed_authors><pubmed_authors>Ness-Jensen E</pubmed_authors><pubmed_authors>Mattsson F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical prediction model for tumor progression in Barrett's esophagus.</name><description>&lt;h4>Background&lt;/h4>Individuals with Barrett's esophagus (BE) are at increased risk of high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC), but the cost-effectiveness of general surveillance of BE is low. This study aimed to identify a risk prediction model for tumor progression in individuals with BE based on age, sex, and risk factors found at upper endoscopy, enabling tailored surveillance.&lt;h4>Methods&lt;/h4>This nested case-control study originated from a cohort of 8171 adults diagnosed with BE in 2006-2013 in the Swedish Patient Registry. Cases had EAC/HGD (n = 279) as identified from the Swedish Cancer Registry, whereas controls had no EAC/HGD (n = 1089). Findings from endoscopy and histopathology reports were extracted from medical records at 71 Swedish hospitals and from the</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2025-04-05T10:42:50.185Z</modification><creation>2019-08-28T07:02:34Z</creation></dates><accession>S-EPMC6684532</accession><cross_references><pubmed>30456503</pubmed><doi>10.1007/s00464-018-6590-5</doi></cross_references></HashMap>